Empowering Patients' Lung Cancer Screening Uptake
Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.
Checked against the public recordLast updated Feb 20, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Screening
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of California, Irvine
- Interventions being studied
- Behavioral: Patient education; Behavioral: Referral to financial navigation resources; Behavioral: Patient Reminders; Behavioral: Provider Reminers
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Patients' Inclusion Criteria: 1. Aged 50- 80 years of age. 2. Be able to Speak English, Spanish, or Vietnamese 3. Must have a scheduled appointment with their Primary Care Providers within next one to three months. 4. The Scheduled PCP appointment is at any of the UCI Health primary care clinics in Orange County including two UCI federally qualified health centers 5. History of 20 pack year smoking history ( based on survey self report) 6. Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self report) Patients' Exclusion Criteria: 1. Prior history of lung cancer 2. chest CT for any reason in the last 12 months based on self-report and UCI EMR 3. history of Alzheimer's disease or dementia Providers' Inclusion Criteria: 1. Primary Care Providers whose patients were enrolled in the Empower LCS trial. 2. Received notifications about the eligibility of their patients for lung cancer screening.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- UCI Health - Costa MesaCosta Mesa, California
- UCI Health Gottschalk Medical PlazaIrvine, California
- UCI Health - Laguna HillsLaguna Hills, California
- UCI Health - Newport Beach MacArthurNewport Beach, California
- UCI Medical CenterOrange, California
- UCI Health - TustinTustin, California
- UCI Health-Yorba LindaYorba Linda, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 20, 2026. Always confirm current availability with the study team.